other cardiovascular — % Change
Products & Services · % ChangeJohnson & Johnson other cardiovascular — % Change remained flat by 0.0% to 5.7% in Q4 2024 compared to the prior quarter. Year-over-year, this metric grew by 8.5%, from 5.3% to 5.7%. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityVolatile
First reportedQ1 2023
Last reportedQ4 2024
How to read this metric
Positive growth signals successful product lifecycle management or market expansion, whereas negative growth may indicate declining demand or the impact of product obsolescence.
Detailed definition
This metric measures the period-over-period percentage growth or decline in revenue for the company's secondary cardiova...
Peer comparison
Comparable to organic revenue growth rates reported by diversified medical device manufacturers for specific sub-segments or product categories.
Metric ID:
jnj_segment_other_cardiovascular_changeHistorical Data
2 years
| FY'23 | FY'24 | |
|---|---|---|
| Value | 21.1% | 22.9% |
| YoY Change | — | +8.5% |
Range21.1% – 22.9%
Avg YoY Growth+8.5%
Median YoY Growth+8.5%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's other cardiovascular — % change?
- Johnson & Johnson (JNJ) reported other cardiovascular — % change of 5.7% in Q4 2024.
- How has Johnson & Johnson's other cardiovascular — % change changed year-over-year?
- Johnson & Johnson's other cardiovascular — % change increased by 8.5% year-over-year, from 5.3% to 5.7%.
- What does other cardiovascular — % change mean?
- The percentage growth or decline in revenue for secondary cardiovascular products compared to a previous period.